Related references
Note: Only part of the references are listed.Upper and lower respiratory tract correlates of protection against respiratory syncytial virus following vaccination of nonhuman primates
Tomer Zohar et al.
CELL HOST & MICROBE (2022)
Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis
You Li et al.
LANCET (2022)
Induction of Mucosal IgA-Mediated Protective Immunity Against Nontypeable Haemophilus influenzae Infection by a Cationic Nanogel-Based P6 Nasal Vaccine
Rika Nakahashi-Ouchida et al.
FRONTIERS IN IMMUNOLOGY (2022)
Selection of HIV Envelope Strains for Standardized Assessments of Vaccine-Elicited Antibody-Dependent Cellular Cytotoxicity-Mediating Antibodies
Dieter Mielke et al.
JOURNAL OF VIROLOGY (2021)
Characterization and Specification of a Trivalent Protein-Based Pneumococcal Vaccine Formulation Using an Adjuvant-Free Nanogel Nasal Delivery System
Yoshikazu Yuki et al.
MOLECULAR PHARMACEUTICS (2021)
The immunogenicity and safety of respiratory syncytial virus vaccines in development: A systematic review
Jing Shan et al.
INFLUENZA AND OTHER RESPIRATORY VIRUSES (2021)
A nanogel-based trivalent PspA nasal vaccine protects macaques from intratracheal challenge with pneumococci
Rika Nakahashi-Ouchida et al.
VACCINE (2021)
Respiratory syncytial virus infection exacerbates pneumococcal pneumonia via Gas6/Axl-mediated macrophage polarization
Takehiko Shibata et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
IGF1R is an entry receptor for respiratory syncytial virus
Cameron D. Griffiths et al.
NATURE (2020)
First-in-human administration of a live-attenuated RSV vaccine lacking the G-protein assessing safety, tolerability, shedding and immunogenicity: a randomized controlled trial
Pauline Verdijk et al.
VACCINE (2020)
Vaccination with ADCC activating HA peptide epitopes provides partial protection from influenza infection
Niloufar Kavian et al.
VACCINE (2020)
Antibody and Local Cytokine Response to Respiratory Syncytial Virus Infection in Community-Dwelling Older Adults
Xiao Yu et al.
MSPHERE (2020)
Comparison of the anesthetic effect by the injection route of mixed anesthesia (medetomidine, midazolam and butorphanol) and the effect of this anesthetic agent on the respiratory function
Hiromi Shibuta et al.
JOURNAL OF VETERINARY MEDICAL SCIENCE (2020)
Prevention of Pediatric Respiratory Syncytial Virus Lower Respiratory Tract Illness: Perspectives for the Next Decade
Sofia S. Aranda et al.
FRONTIERS IN IMMUNOLOGY (2019)
Local and Systemic Immunity against Respiratory Syncytial Virus Induced by a Novel Intranasal Vaccine A Randomized, Double-Blind, Placebo-controlled Clinical Trial
Stephanie Ascough et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)
Adenovectors encoding RSV-F protein induce durable and mucosal immunity in macaques after two intramuscular administrations
N. C. Salisch et al.
NPJ VACCINES (2019)
Antigenic Site-Specific Competitive Antibody Responses to the Fusion Protein of Respiratory Syncytial Virus Were Associated With Viral Clearance in Hematopoietic Cell Transplantation Adults
Xunyan Ye et al.
FRONTIERS IN IMMUNOLOGY (2019)
Fc-Mediated Antibody Effector Functions During Respiratory Syncytial Virus Infection and Disease
Elisabeth A. van Erp et al.
FRONTIERS IN IMMUNOLOGY (2019)
A fatal case associated with respiratory syncytial virus infection in a young child
Lili Xu et al.
BMC INFECTIOUS DISEASES (2018)
Intranasal vaccination against angiotensin II type 1 receptor and pneumococcal surface protein A attenuates hypertension and pneumococcal infection in rodents
Tatsuhiko Azegami et al.
JOURNAL OF HYPERTENSION (2018)
FACS isolation of live mouse eosinophils at high purity via a protocol that does not target Siglec F
Wendy E. Geslewitz et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2018)
A Respiratory Syncytial Virus Vaccine Based on the Small Hydrophobic Protein Ectodomain Presented With a Novel Lipid-Based Formulation Is Highly Immunogenic and Safe in Adults: A First-in-Humans Study
Joanne M. Langley et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
Live Respiratory Syncytial Virus (RSV) Vaccine Candidate Containing Stabilized Temperature-Sensitivity Mutations Is Highly Attenuated in RSV-Seronegative Infants and Children
Ursula J. Buchholz et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
Type I Interferon Potentiates IgA Immunity to Respiratory Syncytial Virus Infection During Infancy
Diego R. Hijano et al.
SCIENTIFIC REPORTS (2018)
Cationic pullulan nanogel as a safe and effective nasal vaccine delivery system for respiratory infectious diseases
Rika Nakahashi-Ouchida et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2018)
Cotton rat lung transcriptome reveals host immune response to Respiratory Syncytial Virus infection
Seesandra V. Rajagopala et al.
SCIENTIFIC REPORTS (2018)
A critical role of Gas6/Axl signal in allergic airway responses during RSV vaccine-enhanced disease
Takehiko Shibata et al.
IMMUNOLOGY AND CELL BIOLOGY (2017)
Respiratory Syncytial Virus: The Influence of Serotype and Genotype Variability on Clinical Course of Infection
Silvia Vandini et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
An Adjuvanted, Postfusion F Protein-Based Vaccine Did Not Prevent Respiratory Syncytial Virus Illness in Older Adults
Judith Falloon et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
Nanogel-based nasal ghrelin vaccine prevents obesity
T. Azegami et al.
MUCOSAL IMMUNOLOGY (2017)
Development and clinical applications of novel antibodies for prevention and treatment of respiratory syncytial virus infection
Asuncion Mejias et al.
VACCINE (2017)
Virus-like particle vaccine primes immune responses preventing inactivated-virus vaccine-enhanced disease against respiratory syncytial virus
Bye Suk Hwang et al.
VIROLOGY (2017)
Ongoing developments in RSV prophylaxis: a clinician's analysis
Fariba Rezaee et al.
CURRENT OPINION IN VIROLOGY (2017)
Advances in Fmoc solid-phase peptide synthesis
Raymond Behrendt et al.
JOURNAL OF PEPTIDE SCIENCE (2016)
Impaired Antibody-mediated Protection and Defective IgA B-Cell Memory in Experimental Infection of Adults with Respiratory Syncytial Virus
Maximillian S. Habibi et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)
Small hydrophobic protein of respiratory syncytial virus as a novel vaccine antigen
Bert Schepens et al.
IMMUNOTHERAPY (2015)
Nonglycosylated G-Protein Vaccine Protects against Homologous and Heterologous Respiratory Syncytial Virus (RSV) Challenge, while Glycosylated G Enhances RSV Lung Pathology and Cytokine Levels
Sandra Fuentes et al.
JOURNAL OF VIROLOGY (2015)
Nanogel-based pneumococcal surface protein A nasal vaccine induces microRNA-associated Th17 cell responses with neutralizing antibodies against Streptococcus pneumoniae in macaques
Y. Fukuyama et al.
MUCOSAL IMMUNOLOGY (2015)
Protection and mechanism of action of a novel human respiratory syncytial virus vaccine candidate based on the extracellular domain of small hydrophobic protein
Bert Schepens et al.
EMBO MOLECULAR MEDICINE (2014)
Preparation and testing of a Vi conjugate vaccine using pneumococcal surface protein A (PspA) from Streptococcus pneumoniae as the carrier protein
Neha Kothari et al.
VACCINE (2014)
Safety and Effectiveness of Palivizumab in Children at High Risk of Serious Disease Due to Respiratory Syncytial Virus Infection: A Systematic Review
Colleen Wegzyn et al.
INFECTIOUS DISEASES AND THERAPY (2014)
Nanogel-Based PspA Intranasal Vaccine Prevents Invasive Disease and Nasal Colonization by Streptococcus pneumoniae
Il Gyu Kong et al.
INFECTION AND IMMUNITY (2013)
Effects of Formalin-Inactivated Respiratory Syncytial Virus (FI-RSV) in the Perinatal Lamb Model of RSV
Rachel J. Derscheid et al.
PLOS ONE (2013)
Architecture of respiratory syncytial virus revealed by electron cryotomography
Lassi Liljeroos et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus
Jason S. McLellan et al.
SCIENCE (2013)
Properties of mouse and human IgG receptors and their contribution to disease models
Pierre Bruhns
BLOOD (2012)
Mechanisms of Respiratory Syncytial Virus Modulation of Airway Immune Responses
Matthew T. Lotz et al.
CURRENT ALLERGY AND ASTHMA REPORTS (2012)
Neutralizing antibodies against the preactive form of respiratory syncytial virus fusion protein offer unique possibilities for clinical intervention
Margarita Magro et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Effect of Three Types of Mixed Anesthetic Agents Alternate to Ketamine in Mice
Sumiko KAWAI et al.
EXPERIMENTAL ANIMALS (2011)
The Airway Antigen Sampling System: Respiratory M Cells as an Alternative Gateway for Inhaled Antigens
Dong-Young Kim et al.
JOURNAL OF IMMUNOLOGY (2011)
Advances in the assessment and control of the effector functions of therapeutic antibodies
Xu-Rong Jiang et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
In Vivo Molecular Imaging Analysis of a Nasal Vaccine That Induces Protective Immunity against Botulism in Nonhuman Primates
Yoshikazu Yuki et al.
JOURNAL OF IMMUNOLOGY (2010)
Nanogel antigenic protein-delivery system for adjuvant-free intranasal vaccines
Tomonori Nochi et al.
NATURE MATERIALS (2010)
Impact of Palivizumab on RSV Hospitalizations for Children with Hemodynamically Significant Congenital Heart Disease
Ruey-Kang R. Chang et al.
PEDIATRIC CARDIOLOGY (2010)
Secretory IgA-mediated protection against V. cholerae and heat-labile enterotoxin-producing enterotoxigenic Escherichia coli by rice-based vaccine
Daisuke Tokuhara et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Compliance with RSV prophylaxis: Global physicians’ perspectives
Anderson
Patient Preference and Adherence (2010)
The cotton rat model of respiratory viral infections
Marina S. Boukhvalova et al.
BIOLOGICALS (2009)
Risk Factors for Respiratory Failure Associated with Respiratory Syncytial Virus Infection in Adults
Coley B. Duncan et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Self-assembled cationic nanogels for intracellular protein delivery
Hirohito Ayame et al.
BIOCONJUGATE CHEMISTRY (2008)
Down syndrome: A novel risk factor for respiratory syncytial virus bronchiolitis - A prospective birth-cohort study
Beatrijs L. P. Bloemers et al.
PEDIATRICS (2007)
Activating Fcγ receptors participate in the development of autoimmune diabetes in NOD mice
Yoshihiro Inoue et al.
JOURNAL OF IMMUNOLOGY (2007)
Differential immune responses and pulmonary pathophysiology are induced by two different strains of respiratory syncytial virus
Nicholas W. Lukacs et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
Function of small hydrophobic proteins of paramyxovirus
RL Wilson et al.
JOURNAL OF VIROLOGY (2006)
Mucosal vaccines: the promise and the challenge
MR Neutra et al.
NATURE REVIEWS IMMUNOLOGY (2006)
A rapid, simple, and humane method for submandibular bleeding of mice using a lancet
WT Golde et al.
LAB ANIMAL (2005)
Nontoxic Shiga toxin derivatives from Escherichia coli possess adjuvant activity for the augmentation of antigen-specific immune responses via dendritic cell activation
M Ohmura et al.
INFECTION AND IMMUNITY (2005)
Mucosal immunity and vaccines
J Holmgren et al.
NATURE MEDICINE (2005)
Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13
N Sigurs et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2005)
Role of IgA versus IgG in the control of influenza viral infection in the murine respiratory tract
KB Renegar et al.
JOURNAL OF IMMUNOLOGY (2004)
Vaccine-enhanced respiratory syncytial virus disease in cotton rats following immunization with Lot 100 or a newly prepared reference vaccine
GA Prince et al.
JOURNAL OF GENERAL VIROLOGY (2001)
Functional analysis of recombinant respiratory syncytial virus deletion mutants lacking the small hydrophobic and/or attachment glycoprotein gene
S Techaarpornkul et al.
JOURNAL OF VIROLOGY (2001)
Recombinant respiratory syncytial viruses with deletions in the NS1, NS2, SH, and M2-2 genes are attenuated in vitro and in vivo
H Jin et al.
VIROLOGY (2000)
Share Paper
